EdenTree Asset Management’s Teladoc Health TDOC Stock Holding History

EdenTree Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-87,480	Closed	-$1.89M	–	75
2023 Q4	$1.89M	Buy	87,480 +350	+0.4%	+$6.46K	0.58%	33
2023 Q3	$1.62M	Buy	87,130 +630	+0.7%	+$14.7K	0.63%	34
2023 Q2	$2.19M	Buy	+86,500	New	+$2.18M	0.75%	33

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

EdenTree Asset Management's TDOC Position: Q1 2024 in Review

EdenTree Asset Management sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 87,480 shares — an estimated $1.89M sold.

EdenTree Asset Management first reported a position in TDOC in Q2 2023 and held it in 3 quarters. The position peaked at $2.19M in Q2 2023. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

EdenTree Asset Management reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
EdenTree Asset Management sold 87,480 Teladoc Health shares in Q1 2024, an estimated $1.89M.
EdenTree Asset Management first reported a position in Teladoc Health in Q2 2023 and held it in 3 quarters.
EdenTree Asset Management's Teladoc Health position peaked at $2.19M in Q2 2023.
426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on EdenTree Asset Management's 13F filing for Q1 2024, filed 15 May 2024.